On September 19, 2023 Development of the Sm14/GLA-SE Schistosomiasis Vaccine Candidate: An Open, Non-Placebo-Controlled, Standardized-Dose Immunization Phase ib Clinical Trial Targeting Healthy Young Women
On March 30, 2023 A randomized, controlled Phase 1b trial of the Sm-TSP-2 Vaccine for intestinal schistosomiasis in healthy Brazilian adults living in an endemic area
On September 9, 2019 A phase 1 study of the safety, reactogenicity, and immunogenicity of a Shicstosoma mansoni vaccine with or without GLA-AF in healthy adults from a non-endemic area
